Eris Lifesciences Limited will hold a board meeting on Monday, October 26, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026, the company said in a filing. The trading window for the company has been closed from October 1, 2026, and will remain closed until 48 hours after the financial results are declared, in accordance with SEBI regulations.